This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: Dispersome IP Aps. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Donglei Leng: Innovator in Pharmaceutical Compositions
Introduction
Donglei Leng is a notable inventor based in Soborg, Denmark. He has made significant contributions to the field of pharmaceutical compositions, particularly through his innovative work involving beta-lactoglobulin. His research focuses on the development of co-amorphous forms that enhance the efficacy of drug substances.
Latest Patents
Donglei Leng holds a patent for "Co-amorphous forms of beta-lactoglobulin and a drug substance." This invention relates to co-amorphous forms of a drug substance and a protein, specifically beta-lactoglobulin, with a purity of at least 92% (w/w) of the total amount of protein in the co-amorphous form. The patent also covers compositions, including pharmaceutical formulations, that utilize this co-amorphous form.
Career Highlights
Throughout his career, Donglei Leng has worked with various companies, including Dispersome IP ApS and Zerion Pharma ApS. His work in these organizations has contributed to advancements in drug formulation and delivery systems.
Collaborations
Donglei has collaborated with notable professionals in his field, including Ole Wiborg and Korbinian Löbmann. These collaborations have further enriched his research and development efforts.
Conclusion
Donglei Leng's innovative work in the pharmaceutical industry, particularly with beta-lactoglobulin, showcases his commitment to advancing drug formulations. His contributions are significant in enhancing the effectiveness of pharmaceutical compositions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile